Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
life sciences
national blog main
national top stories
biotech
boulder/denver blog main
boulder/denver top stories
celgene
detroit blog main
detroit top stories
fda
gene editing
indiana blog main
indiana top stories
johnson & johnson
m&a
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
ac immune
acquisition
alector
alkermes
alliances
alphabet
What
biopharma
3
×
bio
medicine
roundup
approval
betting
billion
car
celgene
colleagues
congress
congressional
crispr
deal
duchenne
executives
exome
fda
feud
gene
government
group
health
historic
hundreds
industry
isn’t
known
later
month
new
ny
pharma
policy
published
puts
ready
recently
rna
roche
Language
unset
Current search:
biopharma
×
" boston top stories "
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More